Search for other papers by Yiqiong Ma in
Google Scholar
PubMed
Search for other papers by Zhaowei Chen in
Google Scholar
PubMed
Search for other papers by Yu Tao in
Google Scholar
PubMed
Search for other papers by Jili Zhu in
Google Scholar
PubMed
Search for other papers by Hongxia Yang in
Google Scholar
PubMed
Search for other papers by Wei Liang in
Google Scholar
PubMed
Search for other papers by Guohua Ding in
Google Scholar
PubMed
Introduction As a severe type of diabetic microangiopathy, diabetic nephropathy (DN) is considered the most common cause of end-stage renal disease (ESRD) worldwide ( 1 ). In China, there are 113.9 million people with diabetes, and the
Search for other papers by Shaomin Shi in
Google Scholar
PubMed
Search for other papers by Xinghua Chen in
Google Scholar
PubMed
Search for other papers by Wen Yu in
Google Scholar
PubMed
Search for other papers by Xiaolan Ke in
Google Scholar
PubMed
Search for other papers by Tean Ma in
Google Scholar
PubMed
Introduction Diabetic nephropathy (DN) is one of the microvascular complications of diabetes, and according to the International Diabetes Federation, the number of people with diabetes is expected to exceed 780 million by 2045 ( 1 ). Diabetic
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Yutong Zou in
Google Scholar
PubMed
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Lijun Zhao in
Google Scholar
PubMed
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Junlin Zhang in
Google Scholar
PubMed
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Yiting Wang in
Google Scholar
PubMed
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Yucheng Wu in
Google Scholar
PubMed
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Honghong Ren in
Google Scholar
PubMed
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Tingli Wang in
Google Scholar
PubMed
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Rui Zhang in
Google Scholar
PubMed
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Jiali Wang in
Google Scholar
PubMed
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Yuancheng Zhao in
Google Scholar
PubMed
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Chunmei Qin in
Google Scholar
PubMed
Search for other papers by Huan Xu in
Google Scholar
PubMed
Search for other papers by Lin Li in
Google Scholar
PubMed
Search for other papers by Zhonglin Chai in
Google Scholar
PubMed
Search for other papers by Mark E Cooper in
Google Scholar
PubMed
Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Nanwei Tong in
Google Scholar
PubMed
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Fang Liu in
Google Scholar
PubMed
Introduction It is well established that diabetic nephropathy (DN) is the first cause of end-stage renal disease (ESRD) in developed and developing countries ( 1 ). In China, both the incidence and prevalence of DN have risen dramatically over
Search for other papers by Ram P Narayanan in
Google Scholar
PubMed
Search for other papers by Bo Fu in
Google Scholar
PubMed
Search for other papers by Adrian H Heald in
Google Scholar
PubMed
Search for other papers by Kirk W Siddals in
Google Scholar
PubMed
Search for other papers by Robert L Oliver in
Google Scholar
PubMed
Search for other papers by Julie E Hudson in
Google Scholar
PubMed
Search for other papers by Antony Payton in
Google Scholar
PubMed
Search for other papers by Simon G Anderson in
Google Scholar
PubMed
Search for other papers by Anne White in
Google Scholar
PubMed
Vascular Research Group, School of Community Based Medicine, Centre for Integrated Genomic Medical Research, Cardiovascular Research Group, Endocrinology and Diabetes, Salford R&D, Department of Endocrinology and Diabetes, Faculty of Medical, Human and Life Sciences, The University of Manchester, Manchester M13 9PT, UK
Search for other papers by William E R Ollier in
Google Scholar
PubMed
Vascular Research Group, School of Community Based Medicine, Centre for Integrated Genomic Medical Research, Cardiovascular Research Group, Endocrinology and Diabetes, Salford R&D, Department of Endocrinology and Diabetes, Faculty of Medical, Human and Life Sciences, The University of Manchester, Manchester M13 9PT, UK
Search for other papers by J Martin Gibson in
Google Scholar
PubMed
Introduction The rising prevalence of diabetes worldwide is associated with increased morbidity and mortality (1) . Diabetic nephropathy is a major complication of diabetes and is the commonest cause of end-stage renal disease (2) . The
The Center for Biomedical Research, Tongji Hospital Research Building, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Search for other papers by Chunliang Yang in
Google Scholar
PubMed
Search for other papers by Junyi Li in
Google Scholar
PubMed
Search for other papers by Fei Sun in
Google Scholar
PubMed
Search for other papers by Haifeng Zhou in
Google Scholar
PubMed
Search for other papers by Jia Yang in
Google Scholar
PubMed
Search for other papers by Chao Yang in
Google Scholar
PubMed
Neurotoxicity Diabetic nephropathy Fuel the Na + reabsorption Secondary hypertension Trigger the production of profibrotic mediators Renal fibrosis Diabetic cardiomyopathy Accelerate Na + entry into myocytes Arrhythmia and heart
Search for other papers by W Liu in
Google Scholar
PubMed
Search for other papers by Y Wang in
Google Scholar
PubMed
Search for other papers by X Han in
Google Scholar
PubMed
Search for other papers by X Cai in
Google Scholar
PubMed
Search for other papers by Y Zhu in
Google Scholar
PubMed
Search for other papers by M Zhang in
Google Scholar
PubMed
Search for other papers by S Gong in
Google Scholar
PubMed
Search for other papers by J Li in
Google Scholar
PubMed
Search for other papers by L Ji in
Google Scholar
PubMed
are the conventionally used predictors of diabetic retinopathy (DR) and diabetic nephropathy (DN). ( 2 , 3 ) Previous studies have shown that almost all T1DM patients are likely to develop some degree of DN within 20 years of diagnosis. ( 4 , 5 ) In
Search for other papers by Tsung-Hui Wu in
Google Scholar
PubMed
Search for other papers by Guan-Yu Su in
Google Scholar
PubMed
Search for other papers by Tsung-Yun Liu in
Google Scholar
PubMed
Institute of Pharmacology, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
PhD Program in Toxicology, Kaohsiung Medical University, Kaohsiung, Taiwan
Search for other papers by Hsiang-Tsui Wang in
Google Scholar
PubMed
Faculty of Medicine, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan
Search for other papers by Chii-Min Hwu in
Google Scholar
PubMed
, 12 , 13 ). Evidence indicates that acrolein may contribute to diabetic retinopathy and diabetic nephropathy ( 14 , 15 ). Recently, Yao et al. found that treatment with hydralazine, an acrolein scavenger, attenuated neuroinflammation and
Search for other papers by Yu Ah Hong in
Google Scholar
PubMed
Search for other papers by Kyung-Do Han in
Google Scholar
PubMed
Search for other papers by Jae-Seung Yun in
Google Scholar
PubMed
Search for other papers by Eun Sil Sil in
Google Scholar
PubMed
Search for other papers by Seung-Hyun Ko in
Google Scholar
PubMed
Search for other papers by Sungjin Chung in
Google Scholar
PubMed
Introduction Diabetic nephropathy is a major microvascular complication of type 2 diabetes mellitus (DM), and in many countries of the world, it is the major cause of end-stage renal disease (ESRD) ( 1 , 2 , 3 ). Identification of high
Search for other papers by Qian Deng in
Google Scholar
PubMed
Search for other papers by Yue Zhu in
Google Scholar
PubMed
Search for other papers by Mengmeng Zhang in
Google Scholar
PubMed
Search for other papers by Aihua Fei in
Google Scholar
PubMed
Search for other papers by Jiaqi Liang in
Google Scholar
PubMed
Search for other papers by Jinjin Zheng in
Google Scholar
PubMed
Search for other papers by Qingping Zhang in
Google Scholar
PubMed
Search for other papers by Tong Cheng in
Google Scholar
PubMed
Search for other papers by Xia Ge in
Google Scholar
PubMed
nephropathy Diabetic nephropathy (DN) is one of the serious microvascular complications of diabetes and the leading cause of end-stage renal disease worldwide ( 28 ). Regardless of glycemic control, all diabetic patients will potentially develop DN ( 29
Faculty of Medicine, University of Oslo, Oslo, Norway
Search for other papers by Espen Nordheim in
Google Scholar
PubMed
Faculty of Medicine, University of Oslo, Oslo, Norway
Metabolic and Renal Research Group, Faculty of Health Sciences, UiT- The Arctic University of Norway, Tromsø
Search for other papers by Trond Geir Jenssen in
Google Scholar
PubMed
. This review is based on literature search in Pubmed with the following combinations of keywords: 'diabetic nephropathy', 'diabetic kidney disease', 'diabetic nephropathy treatment' and 'diabetic kidney disease treatment' to complete our own bibliography